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There is growing recognition that animal transcription factors bind in vivo to far more genomic regions than
generally assumed earlier. In this issue of Developmental Cell, Cao et al. show that the muscle specification
factor MyoD binds to regions near most genes and modifies chromatin states at these sites.To understand how animal transcription
factors specify developmental fates, it is
essential to determine the full range of
genes that these proteins bind and regu-
late in vivo. The majority of factors recog-
nize short degenerate DNA sequences—
often just 6–10 bp long—that occur
frequently throughout the length of most
gene loci (Wunderlich and Mirny, 2009).
While only a subset of these recognition
sites occurrences are highly occupied in
the animal, in vivo crosslinking experi-
ments have increasingly detected many
regulators that each bind to regions close
to a large proportion of genes (reviewed in
MacArthur et al., 2009). Recent work by
Cao et al. (2010) provides a particularly
dramatic example of such widespread
DNA binding for the muscle regulator
MyoD. They further show that this binding
leads to increased acetylation of histones
at tens of thousands of genomic regions.
How is such widespread DNA binding
and chromatin modification related to
the regulatory functions of this and other
transcription factors?
MyoD is a classic master regulator that
commits those somite cells in which it is
expressed toamyoblast fateandalso later
activates skeletalmuscle genes during the
differentiation of these cells. It is a bHLH
factor that binds either as a homodimer
or as a heterodimer with other bHLH
proteins to variants of the E-box con-
sensus sequence CANNTG and acts in
a context-dependant manner together
with other muscle-specific and general
developmental transcription factors. For
example, MyoD is present in cultured
mousemyoblast cells, but it only activates
transcriptionof skeletalmuscle genesafter
these cells have been transferred into low-
mitogenconditions to induce the formation
of myotube cells, presumably because
MyoD’s activity is altered by induced
changes in its interacting partners.Previous in vivo crosslinking studies
using microarrays identified 120–200 pro-
ximal promoters bound by MyoD (Blais
et al., 2005; Cao et al., 2006). Using a
more sensitive ChIP-seq assay, Cao
et al. (2010) have now identified more
genomic regions bound by mouse MyoD
in cultured myoblasts and myotubes. At
least 30,000 regions of several hundred
base pairs each were detected, with a
majority of genes being close to or in-
cluding at least one MyoD bound region.
While MyoD occupancy did not change
at most of these regions during the differ-
entiation of cultured myoblasts into myo-
tubes, it did alter significantly at 5,000
of the regions. Those regions where
binding increased tend to be close to
muscle formation genes and geneswhose
expression was upregulated during differ-
entiation, whereas those in which binding
decreased tend to be associated with
cell proliferation and cell communication
genes as well as genes whose expression
was reduced upon differentiation. Thus,
the changes in MyoD occupancy at
many of these regions probably caused
the >2-fold changes in mRNA expression
that were observed for 4% of genes
upon differentiation.
But what about the remaining tens of
thousands of regions bound by MyoD
near most other genes whose expression
did not change? Studies in other systems
have established that transcription fac-
tors bind over a quantitative continuum
and that while highly bound regions on
average map to known and likely func-
tional cis regulatory modules, many of
the thousands of regions occupied at
approximately 10-fold lower levels are
probably nonfunctional (Fullwood et al.,
2009; MacArthur et al., 2009). For
example, poorly bound regions tend to
be located near untranscribed genes,
near uniformly expressed genes, inDevelopmental Celprotein coding regions, or in less well-
conserved regions of noncoding DNA.
Indeed, such widespread, nonfunctional
transcription factor binding has long
been recognized as thermodynamically
inevitable, at least at accessible parts of
chromatin. Given the concentrations of
both transcription factors and their DNA
recognition sites in cells and the affinities
of the two for each other, transcription
factor molecules should reside on DNA
most of the time, rather than being free
in solution in the nucleus (Lin and Riggs,
1975). Thus, there is no reason to assume
that all DNA binding detected in vivo is
functional.
Cao et al. (2010), however, provide
evidence that MyoD induces a biochem-
ical change to chromatin at a high propor-
tion of the regions it binds. The authors
compared histone modification states
between mouse fibroblasts and mouse
fibroblasts that have been transformed
into skeletal muscle by the expression of
MyoD. At most of the tens of thousands
of regions bound by MyoD in the trans-
formed cells, histone H4 acetylation is
markedly increased compared to the
levels in normal fibroblasts. Since this
histone acetylation is associated with
tissue-specific, transcriptionally active
cis regulatory regions (Heintzman et al.,
2009), widespread acetylation has the
potential to affect transcription at a high
percent of genes. As with the previously
described analysis of myoblast differenti-
ation, however, microarray expression
analysis revealed that far fewer genes
(4%) show significant (>2-fold) changes
in mRNA expression than show MyoD-
induced acetylation (Cao et al., 2010).
Thus, either most acetylation events are
nonfunctional or their role is not revealed
by the current cultured cell assays.
Studies in the Drosophila embryo
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the embryo, most randomly selected
genes show unique, quantitative changes
in expression between cells, even be-
tween neighbors of the same cell type.
Such within-cell-type gene expression-
regulation is controlled by factors, such
as HOX proteins, that specify positional
information within an organism (Wolpert,
1994). These transcription factors have
exceptionally broad regulatory effects,
each directly or indirectly coordinating
the expression of 60% of genes by
2-fold or more (Liang and Biggin, 1998).
Cells within a muscle or any other animal
tissue are not identical to each other, but
differ in qualities such as shape, size,
and cell contacts in order to create the
required tissue structure. The control of
such subtle differences between cells of
the same type may require modest quan-
titative changes in the expression ratios
of a large percent of genes (Liang and506 Developmental Cell 18, April 20, 2010 ª2Biggin, 1998). Thus, it is plausible that
MyoD may control many more genes in
the animal than suggested by expression
analysis of cultured cells through interac-
tionswith transcription factors that specify
positional value and that are active in
differing parts of the developing muscle.
Nevertheless, not all DNA binding and
acetylation events in the genome are
likely functional. It will be the next major
challenge to discover, in the context of
the organism, what fraction of factor
DNA binding and chromatin modification
events lead to detectable transcriptional
responses and what fraction of these
responses offer an evolutionary selective
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Recently reporting inNature, Collinet et al. describes the application of quantitativemultiparametricmethods
to a genome-wide RNAi screen for regulators of endocytosis. The study illustrates the power of this approach
beyond the identification of new endocytic components to providing insights into the design principles of the
endocytic system.One of the goals of systems biology is
to understand how specific cellular pro-
cesses operate and are integrated in the
overall higher order unit—the cell. In
recent years, genome-wide RNAi high-
throughput screens (HTS) have provided
the means to functionally interrogate the
entire genome. Arguably, the most ex-
citing application of HTS RNAi screening
is not simply to use the methodology to
identify new components of a biological
process, but to gain a broader under-standing of how the regulation of a single
process is dynamically coordinated with
others (Mathey-Prevot and Perrimon,
2006). However, the promise of using
HTS RNAi technology to gain systems
level understanding and todescribe emer-
gent cellular behaviors has been slow to
be realized, largely because of setbacks
due to the high rate of false positives
created by initially unexpected off-target
effects (OTEs) of RNAi reagents. In a new
study recently published inNature, MarinoZerial and colleagues make use of exten-
sive resources and elegant data analysis
methods to drastically limit OTEs, thus
providing a striking example of how a
genome-wide HTS screen performed in
a rigorous and quantitative manner can
lead tosystems-wide insights intoa funda-
mental cellular process—in this case, that
of endocytosis (Collinet et al., 2010).
Endocytosis is a means by which cells
absorb molecules and particles (such as
nutrients, signaling molecules, and
